IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 247 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $13,046,977 | +23.5% | 1,140,470 | +4.0% | 0.05% | +15.0% |
| Q3 2023 | $10,560,932 | -0.4% | 1,096,670 | +10.0% | 0.04% | +2.6% |
| Q2 2023 | $10,606,271 | +7.0% | 996,830 | +5.8% | 0.04% | +2.6% |
| Q1 2023 | $9,911,523 | +0.8% | 942,160 | +18.7% | 0.04% | 0.0% |
| Q4 2022 | $9,831,713 | +143.7% | 793,520 | +103.8% | 0.04% | +123.5% |
| Q3 2022 | $4,034,000 | – | 389,380 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 16,390,000 | $183,240,000 | 17.56% |
| HealthInvest Partners AB | 1,450,000 | $16,211,000 | 12.91% |
| Healthcare Value Capital, LLC | 200,000 | $2,236,000 | 4.98% |
| BRIDGER MANAGEMENT, LLC | 2,852,414 | $31,890,000 | 2.98% |
| Camber Capital Management LP | 7,500,000 | $83,850,000 | 2.88% |
| 13D Management LLC | 658,017 | $7,357,000 | 2.72% |
| Brown Capital Management | 20,170,126 | $225,502,000 | 1.68% |
| Healthcare Value Capital, LLC | 50,000 | $559,000 | 1.24% |
| Zebra Capital Management LLC | 59,122 | $661,000 | 0.73% |
| PRICE MICHAEL F | 520,000 | $5,814,000 | 0.70% |